206 related articles for article (PubMed ID: 24268690)
1. Comparative functional characterization of canine IgG subclasses.
Bergeron LM; McCandless EE; Dunham S; Dunkle B; Zhu Y; Shelly J; Lightle S; Gonzales A; Bainbridge G
Vet Immunol Immunopathol; 2014 Jan; 157(1-2):31-41. PubMed ID: 24268690
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
[TBL] [Abstract][Full Text] [Related]
3. IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides.
Niwa R; Natsume A; Uehara A; Wakitani M; Iida S; Uchida K; Satoh M; Shitara K
J Immunol Methods; 2005 Nov; 306(1-2):151-60. PubMed ID: 16219319
[TBL] [Abstract][Full Text] [Related]
4. In vitro functional characterization of feline IgGs.
Strietzel CJ; Bergeron LM; Oliphant T; Mutchler VT; Choromanski LJ; Bainbridge G
Vet Immunol Immunopathol; 2014 Apr; 158(3-4):214-23. PubMed ID: 24560097
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes.
Voice JK; Lachmann PJ
Eur J Immunol; 1997 Oct; 27(10):2514-23. PubMed ID: 9368604
[TBL] [Abstract][Full Text] [Related]
6. Human monocyte-mediated cytotoxicity towards erythrocytes induced by hybrid mouse monoclonal antibodies: effect of antibody binding valency on IgG-Fc gamma R interaction.
Koolwijk P; Van de Winkel JG; Otten I; Bast BJ
Immunology; 1992 Feb; 75(2):336-42. PubMed ID: 1532380
[TBL] [Abstract][Full Text] [Related]
7. Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region.
Michaelsen TE; Aase A; Norderhaug L; Sandlie I
Mol Immunol; 1992 Mar; 29(3):319-26. PubMed ID: 1557042
[TBL] [Abstract][Full Text] [Related]
8. Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.
Repp R; Kellner C; Muskulus A; Staudinger M; Nodehi SM; Glorius P; Akramiene D; Dechant M; Fey GH; van Berkel PH; van de Winkel JG; Parren PW; Valerius T; Gramatzki M; Peipp M
J Immunol Methods; 2011 Oct; 373(1-2):67-78. PubMed ID: 21855548
[TBL] [Abstract][Full Text] [Related]
9. Compensation of endogenous IgG mediated inhibition of antibody-dependent cellular cytotoxicity by glyco-engineering of therapeutic antibodies.
Nechansky A; Schuster M; Jost W; Siegl P; Wiederkum S; Gorr G; Kircheis R
Mol Immunol; 2007 Mar; 44(7):1815-7. PubMed ID: 17011625
[TBL] [Abstract][Full Text] [Related]
10. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications.
van de Winkel JG; Capel PJ
Immunol Today; 1993 May; 14(5):215-21. PubMed ID: 8517920
[TBL] [Abstract][Full Text] [Related]
11. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
[TBL] [Abstract][Full Text] [Related]
12. High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism.
Mishima Y; Terui Y; Mishima Y; Kuniyoshi R; Matsusaka S; Mikuniya M; Kojima K; Hatake K
Int Immunol; 2012 Aug; 24(8):477-83. PubMed ID: 22438420
[TBL] [Abstract][Full Text] [Related]
13. The functional activity of Fc gamma RII and Fc gamma RIII on subsets of human lymphocytes.
Hadley AG; Zupanska B; Kumpel BM; Leader KA
Immunology; 1992 Jul; 76(3):446-51. PubMed ID: 1356095
[TBL] [Abstract][Full Text] [Related]
14. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.
Davies J; Jiang L; Pan LZ; LaBarre MJ; Anderson D; Reff M
Biotechnol Bioeng; 2001 Aug; 74(4):288-94. PubMed ID: 11410853
[TBL] [Abstract][Full Text] [Related]
15. Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa.
Iida S; Misaka H; Inoue M; Shibata M; Nakano R; Yamane-Ohnuki N; Wakitani M; Yano K; Shitara K; Satoh M
Clin Cancer Res; 2006 May; 12(9):2879-87. PubMed ID: 16675584
[TBL] [Abstract][Full Text] [Related]
16. [Immunology in clinical practice. X. IgG receptors: structure, function and immunotherapy].
van der Pol WL; van de Winkel JG
Ned Tijdschr Geneeskd; 1998 Feb; 142(7):335-40. PubMed ID: 9562738
[TBL] [Abstract][Full Text] [Related]
17. High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G.
Preithner S; Elm S; Lippold S; Locher M; Wolf A; da Silva AJ; Baeuerle PA; Prang NS
Mol Immunol; 2006 Mar; 43(8):1183-93. PubMed ID: 16102830
[TBL] [Abstract][Full Text] [Related]
18. Abatacept binds to the Fc receptor CD64 but does not mediate complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicity.
Davis PM; Abraham R; Xu L; Nadler SG; Suchard SJ
J Rheumatol; 2007 Nov; 34(11):2204-10. PubMed ID: 17787038
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant IFN-gamma (rIFN-gamma) on the mechanism of human macrophage IgG FcRI-mediated cytotoxicity. rIFN-gamma decreases inhibition by cytophilic human IgG and changes the cytolytic mechanism.
Van Schie RC; Verstraten RG; Van de Winkel JG; Tax WJ; de Mulder PH
J Immunol; 1992 Jan; 148(1):169-76. PubMed ID: 1530794
[TBL] [Abstract][Full Text] [Related]
20. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region.
Natsume A; Wakitani M; Yamane-Ohnuki N; Shoji-Hosaka E; Niwa R; Uchida K; Satoh M; Shitara K
J Immunol Methods; 2005 Nov; 306(1-2):93-103. PubMed ID: 16236307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]